Clinical Trial Update: 8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial investigates 8-Chloroadenosine for relapsed or refractory acute myeloid leukemia, with completed results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia Arising From Prior Myelodysplastic Syndrome

Drugs mentioned

• 8-Chloroadenosine (8-chloroadenosine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-05